Literature DB >> 87725

Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump.

W V Tamborlane, R S Sherwin, M Genel, P Felig.   

Abstract

To determine whether abnormalities of lipid and aminoacid metabolism observed in diabetes are corrected when plasma-glucose levels are restored to normal, eight insulin-dependent diabetics were treated for 7-14 days with a portable infusion pump which delivers insulin subcutaneously in basal (between-meal) doses with pulse-dose increments before meals. Mean plasma-glucose (206 +/- 24 mg/dl during conventional insulin treatment) fell to 89 +/- 3 mg/dl at day 7 and 84 +/- 2 mg/dl at day 14 of pump treatment; glycosuria was eliminated. Plasma cholesterol, triglycerides, and free fatty acids were elevated during conventional insulin treatment but fell to normal after 7 days of pump treatment. Plasma-levels of branched-chain aminoacids were 50-60% above control levels during conventional treatment but fell to normal after 7 days of pump therapy. Aminoacids were reduced from their high postprandial levels to normal values after insulin-pump treatment. In addition to restoring plasma-glucose to normal, treatment of diabetes with a portable insulin-infusion system results in restoration of normal lipid and aminoacid metabolism. Long-term use of this system may determine whether metabolic changes resulting from insulin lack cause the complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 87725     DOI: 10.1016/s0140-6736(79)92226-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

1.  'Do-it-yourself' insulin pump. Case report.

Authors:  D Bruttomesso; G Lisato; S Del Prato; A Tiengo
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

2.  Continuous subcutaneous insulin infusion: a long-term study.

Authors:  A Lombardo; S Scavino; G Scornavacca; G Oliva; C Sipione; R Cacciola; L Motta
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar

3.  Relationship between metabolic control and HDL2-cholesterol in type I diabetic patients.

Authors:  L Beccaria; D Sommariva; F Meschi; M G Boga; A Branchi; I Pogliaghi; C Ottomano; G Chiumello
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun

4.  Osmotically powered drug-delivery pump using semipermeable hollow fibre.

Authors:  S Tanaka; K Yamakoshi; A Kamiya; H Shimazu; T Togawa
Journal:  Med Biol Eng Comput       Date:  1986-07       Impact factor: 2.602

5.  The metabolic and hormonal effects of continuous subcutaneous insulin infusion therapy in diabetic children.

Authors:  G Soltész; D Molnár; T Decsi; A Hamar; L Klujber
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

Review 6.  Technology and the diabetic patient.

Authors:  J C Pickup; D Rothwell
Journal:  Med Biol Eng Comput       Date:  1984-09       Impact factor: 2.602

7.  The effect of continuous subcutaneous insulin infusion and conventional insulin regimes on 24-hour variations of blood glucose and intermediary metabolites in the third trimester of diabetic pregnancy.

Authors:  J M Potter; J P Reckless; D R Cullen
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

8.  Human noninsulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E.

Authors:  C J Fielding; G M Reaven; P E Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

9.  Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion.

Authors:  I Lager; P Lönnroth; H von Schenck; U Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

10.  Improvement of glucose homeostasis in insulin-dependent diabetics using a miniature insulin infusion pump with a fixed profile.

Authors:  K Køolendorf; J Bojsen; B Løorup
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.